Comprehensive Management of Cardiovascular Conditions

Initial Pharmacological Management

The European Society of Cardiology recommends beta-blockers as essential for treating angina, arrhythmias, hypertension, and heart failure, reducing both symptoms and mortality 1, 2
The American College of Cardiology recommends ACE inhibitors for patients with heart failure, coronary artery disease, and hypertension to improve symptoms and reduce morbidity and mortality 1, 3
Aspirin (75-325 mg daily) should be used routinely in all patients with coronary artery disease to prevent myocardial infarction and death, as recommended by the American College of Cardiology 3, 4
High-intensity statin therapy is indicated to reduce LDL-C to less than 70 mg/dL for secondary prevention in patients with established coronary artery disease, according to the American College of Cardiology 5, 7

The American College of Cardiology recommends smoking cessation using a stepwise approach (Ask, Advise, Assess, Assist, Arrange) with pharmacotherapy including nicotine replacement as needed 5, 7
Dietary modifications should include reduced intake of saturated fats (<7% of total calories), limited sodium intake, and increased consumption of omega-3 fatty acids, fresh fruits, and vegetables, as recommended by the American College of Cardiology 5, 7
Blood pressure should be controlled to <140/90 mmHg, or <130/80 mmHg for patients with diabetes or chronic kidney disease, according to the American College of Cardiology 5, 7

The European Society of Cardiology recommends coronary angiography (with FFR/iwFR when necessary) for patients with severe coronary artery disease with symptoms refractory to medical treatment, high-risk clinical profile, or angina persisting despite optimal medical therapy 1, 8
Myocardial revascularization is recommended when angina persists despite treatment with antianginal drugs, as recommended by the European Society of Cardiology and the American College of Cardiology 1, 2

The American College of Cardiology recommends classifying chest pain as typical, atypical, or noncardiac based on characteristics, and using beta-blockers as first-line therapy for angina 8
For heart failure, the European Society of Cardiology recommends optimizing fluid status with diuretics, using beta-blockers, ACE inhibitors, and MRAs in a stepwise approach, and considering angiotensin receptor-neprilysin inhibitor in patients with persistent symptoms despite optimal medical therapy 1, 2
For arrhythmias, the American College of Cardiology recommends identifying and classifying the arrhythmia type before specific treatment, controlling ventricular rate with beta-blockers, and providing anticoagulation for atrial fibrillation 2

The European Society of Cardiology recommends regular reassessment of cardiovascular status, including clinical evaluation of lifestyle modifications and adherence to medication 1
Periodic assessment of lipid profile, renal function, and electrolytes is recommended by the American College of Cardiology and the Annals of Internal Medicine 4, 5
Risk stratification using stress imaging or exercise stress ECG is recommended for patients with new or worsening symptoms, according to the European Society of Cardiology 1